Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats

Diabetes

Volumn 52, Issue 3, 2003, Pages 818-823

  Kowluru, Renu A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

GC, good glycemic control; GSH, reduced glutathione; iNOS, inducible nitric oxide synthase; LPO, lipid peroxide; NO, nitric oxide; PC, poor glycemic control

Indexed keywords

3 NITROTYROSINE; GLUCOSE; LIPID PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TIME SERIES ANALYSIS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLUTATHIONE; HYPERGLYCEMIA; INSULIN; LIPID PEROXIDES; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; TYROSINE;

EID: 0037342855     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.3.818     Document Type: Article

References (37)

1. Engerman RL, Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36:808-812, 1987
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
4. Robison WGJ, Laver NM, Jacot JL, Chandler ML, York BM, Glover JP: Efficacy of treatment after measurable diabetic like retinopathy in galactose-fed rats. Invest Ophthalmol Vis Sci 38:1066-1073, 1997
5. Robison WG, Jacot JL, Glover JP, Basso MD, Hohman TC: Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats. Invest Ophthalmol Vis Sci 39:1933-1941, 1998
6. Wolff SP: The potential role of oxidative stress in diabetes and its complications: novel implications for theory and therapy. In Diabetic Complications: Scientific and Clinical Aspects. Crabbe MJC, Ed. London, Churchill Livingston, 1987, p. 167-221
7. Armstrong D, Abdella N, Salman A, Miller N, Rahman EA, Bojancyzk M: Relationship of lipid peroxides to diabetic complications. J Diabetes Complications 6:116-122, 1992
8. Kowluru RA, Tang J, Kern TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50:1938-1942, 2001
9. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150:523-531, 1997
10. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
11. Jennings PE, McLaren M, Scott NA, Saniabadi AR, Belch JJF: The relationship of oxidative stress to thrombotic tendency in type I diabetic patients with retinopathy. Diabet Med 8:860-865, 1991
12. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
13. Kowluru RA, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Rad Biol Med 22:587-592, 1996
14. Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes. Diabetes 36:1014-1018, 1987
15. Behar-Cohen FF, Heydolph S FV, Droy-Lefaix MT, Courtois Y, Goureau O: Peroxynitrlte cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochem Biophys Res Commun 226:842-849, 1996
16. Halliwell B: What nitrates tyrosine? Is nitrotyrosine specific as a biomaker of peroxynitrite formation in vivo? FEBS Lett 411:157-160, 1997
17. Du Y, Smith MA, Miller CM, Kern TS: Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771-779, 2002
18. Kowluru RA, Chakrabarti S, Chen S: Nuclear transcriptional factor (NF-kB) remains activated in the retina of diabetic rats when retinopathy is developing, and antioxidants inhibit this activation (Abstract). Diabetes 51:A201, 2002
19. Kowluru RA, Chakrabarti S, Chen S: Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Diabetes. In press
20. Mizutani M, Kern TS, Lorenzi M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883-2890, 1996
21. Kowluru A: Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are inter-related. Acta Diabetologica 38:179-185, 2001
22. Kowluru RA, Koppolu P: Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities. Inves Ophthalmol Vis Sci 43:3287-3291, 2002
23. Kowluru RA, Koppolu P: Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Rad Res 36:993-999, 2002
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein. Anal Biochem 72:248-258, 1974
25. Szabo ME, Haines D, Garay E, Chiavaroli C, Farine JC, Hannaert P, Berta A, Garay RP: Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina. Eur J Pharmacol 428:277-286, 2001
26. Li W, Yanoff M, Jian B, He Z: Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol Biol 45:59-66, 1999
27. Robison WG, Jacot JL, Katz ML, Glover JP: Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther 16:109-120, 2000
28. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
29. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232, 1993
30. Hattenbach LO, Allers A, Klais C, Koch F, Hecker M: L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients. Invest Ophthalmol Vis Sci 41:213-217, 2000
31. Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P: Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 14:285-295, 1995
32. Sennlaub F, Courtois Y, Goureau O: Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. J Neurosci 22:3987-3993, 2002
33. Schmetterer L, Findl O, Fasching P, Ferber W, Strenn K, Breiteneder H, Adam H, Eichler HG, Wolzt M: Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 653-658, 1997
34. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437, 1996
35. Engerman RL, Bloodworth JMB Jr, Nelson S: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26:760-769, 1977
36. Hammes H-P, Klinzing I, Wiegand S, Bretzel RG, Cohen AM, Federlin K: Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol Vis Sci 34:2092-2096, 1993
37. Kador PF, Takahashi Y, Akagi Y, Neuenschwander H, Greentree W, Lackner P, Blessing K, Wyman M: Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Invest Ophthalmol Vis Sci 43:1916-1921, 2002